BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 8765102)

  • 1. Thermodynamic and Structural Study of Budesonide-Exogenous Lung Surfactant System.
    Keshavarzi A; Asi Shirazi A; Korfanta R; Královič N; Klacsová M; Martínez JC; Teixeira J; Combet S; Uhríková D
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential scanning calorimetry and small angle x-ray diffraction study of the interaction of (R)-PAF, (R)-ET-18-OME and (R)-Lyso-PAF with model membranes.
    Xie XQ; Moring J; Makriyannis A
    Life Sci; 1997; 61(9):909-23. PubMed ID: 9284084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of platelet-activating factor (PAF), lyso-PAF and lysophosphatidylcholine on phosphatidylcholine bilayers, an ESR, 31P-NMR and X-ray diffraction study.
    Olivier JL; Chachaty C; Quinn PJ; Wolf C
    J Lipid Mediat; 1991; 3(3):311-32. PubMed ID: 1663404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative characteristics of membrane-active single-chained ether phospholipids: PAF and lyso-PAF in Langmuir monolayers.
    Flasiński M; Broniatowski M; Wydro P; Dynarowicz-Łątka P
    J Phys Chem B; 2012 Mar; 116(10):3155-63. PubMed ID: 22316066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermotropic and barotropic phase transitions in bilayer membranes of ether-linked phospholipids with varying alkyl chain lengths.
    Matsuki H; Miyazaki E; Sakano F; Tamai N; Kaneshina S
    Biochim Biophys Acta; 2007 Mar; 1768(3):479-89. PubMed ID: 17141731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of polymerizable lipid bilayers. V. Synthesis, bilayer structure and properties of diacetylenic ether and ester lipids.
    Rhodes DG; Xu Z; Bittman R
    Biochim Biophys Acta; 1992 Sep; 1128(1):93-104. PubMed ID: 1390881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interdigitation of bilayers from ether lipid analogs: (R)-PAF, (R)-Lyso-PAF and the antineoplastic (R)-ET-18-OMe.
    Xie X; Lin S; Moring J; Makriyannis A
    Biochim Biophys Acta; 1996 Aug; 1283(1):111-8. PubMed ID: 8765102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of platelet activating factor and related ether lipids: enzymatic pathways, subcellular sites, regulation, and membrane processing.
    Snyder F
    Prog Clin Biol Res; 1988; 282():57-72. PubMed ID: 3071807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid bilayers: thermodynamics, structure, fluctuations, and interactions.
    Tristram-Nagle S; Nagle JF
    Chem Phys Lipids; 2004 Jan; 127(1):3-14. PubMed ID: 14706737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosidated phospholipids - a promising group of anti-tumour lipids.
    Semini G; Hildmann A; von Haefen C; Danker K
    Anticancer Agents Med Chem; 2014 May; 14(4):607-17. PubMed ID: 24628240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of peroxisomes in ether lipid synthesis. Back to the roots of PAF.
    van den Bosch H; de Vet EC; Zomer AW
    Adv Exp Med Biol; 1996; 416():33-40. PubMed ID: 9131123
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.
    Danker K; Reutter W; Semini G
    Br J Pharmacol; 2010 May; 160(1):36-47. PubMed ID: 20331609
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.